MAM
RVMD icon

Meeder Asset Management’s Revolution Medicines RVMD Stock Holding History

Meeder Asset Management’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.3K Sell
39
-67
-63% -$9.79K ﹤0.01% 777
2026
Q1 		$10.3K Buy
106
+35
+49% +$3.53K ﹤0.01% 690
2025
Q4 		$5.66K Sell
71
-25
-26% -$1.64K ﹤0.01% 777
2025
Q3 		$4.48K Buy
96
+19
+25% +$744 ﹤0.01% 691
2025
Q2 		$2.83K Buy
+77
New +$2.96K ﹤0.01% 784
2025
Q1 		– Sell
-88
Closed -$3.85K – 1029
2024
Q4 		$3.85K Sell
88
-14
-14% -$707 ﹤0.01% 860
2024
Q3 		$4.63K Buy
102
+30
+42% +$1.31K ﹤0.01% 756
2024
Q2 		$2.79K Buy
+72
New +$2.69K ﹤0.01% 831
2020
Q4 		– Sell
-425
Closed -$14K – 2164
2020
Q3 		$14K Buy
+425
New +$11.8K ﹤0.01% 1271

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Meeder Asset Management's RVMD Position: Q2 2026 in Review

Meeder Asset Management reduced its Revolution Medicines (RVMD) stake by 63% in Q2 2026, selling an estimated $9.79K and leaving 39 shares worth $7.3K. The position accounts for ﹤0.01% of the portfolio, ranked #777.

Meeder Asset Management first reported a position in RVMD in Q3 2020 and has held it in 9 quarters since. The position peaked at $14K in Q3 2020. 694 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Meeder Asset Management held 39 shares of Revolution Medicines worth $7.3K as of Q2 2026.
  • Meeder Asset Management sold 67 Revolution Medicines shares in Q2 2026, an estimated $9.79K.
  • Revolution Medicines made up ﹤0.01% of Meeder Asset Management's portfolio in Q2 2026, its #777 holding.
  • Meeder Asset Management first reported a position in Revolution Medicines in Q3 2020 and has held it in 9 quarters since.
  • Meeder Asset Management's Revolution Medicines position peaked at $14K in Q3 2020.
  • 694 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Meeder Asset Management's 13F filing for Q2 2026, filed 7 Aug 2026.